Comvita (CVT) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
24 Dec, 2025Executive summary
Reported a net loss of $6.5M for the first half of FY25, compared to a $2.5M loss in the same period last year (restated), with revenue down 5% to $99.7M and gross profit down 20% to $50.5M.
Significant inventory reduction and improved cash flow performance achieved through operational refinements and cost controls.
Accounting irregularities in China and Singapore subsidiaries led to restatements, tighter internal controls, and a culture reset focused on trust and transparency.
Ongoing restructuring includes headcount and board reductions, cost savings, and a "back to basics" repositioning to restore operational focus.
Market and industry conditions remain challenging, but outlook is improving into FY26.
Financial highlights
Revenue for HY25 was $99.7M, down 5.3% year-over-year; gross profit was $50.5M, down 20.1%, with gross margin declining to 50.7% from 60.0%.
Operating cash flow improved to $9.8M, a $16M increase year-over-year; free cash flow positive at $2.0M, up $28M year-over-year.
Net debt at $81.6M at period end, down $16.5M over Q2, with inventory reduced by $15M since June 2024.
Operating expenses decreased by 8.5% to $56.0M; restructuring costs of $2.1M incurred in the half.
Basic and diluted EPS: (9.21) NZ cents, compared to (3.50) NZ cents year-over-year.
Outlook and guidance
Sales expected to remain flat through FY25 and FY26, with China market soft and gradual improvement in Asia and North America.
Margins have stabilized, with further improvement anticipated as lower cost inventory flows through.
Full benefits of restructuring and cost savings expected to be realized in FY26.
Directors remain confident in ongoing bank support and constructive lender negotiations.
Industry honey harvests projected to be below average in 2024 and 2025, but supply security is strong.
Latest events from Comvita
- Net profit $4.6m, revenue $118m, strong cash flow; North America drives growth, recapitalisation ongoing.CVT
H1 202623 Feb 2026 - Margin pressures, cost reduction, and strategic transformation drive the company's reset.CVT
AGM 20243 Feb 2026 - Revenue and profit fell sharply amid impairments and market contraction, with cost cuts in progress.CVT
H2 202423 Jan 2026 - Financial reset, recapitalisation, and board changes drive growth amid market challenges.CVT
AGM 202517 Dec 2025 - Revenue down 4.1%, major loss from impairments, but cash flow and debt improved; 67% premium offer.CVT
H2 202523 Nov 2025